Position in CELC
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$3,740,478
-$340,369 QoQ
Shares Held
35,753
0.0% QoQ
Ownership
0.073%
of shares outstanding
% of Portfolio
1.81%
of 13F equity value
Holder Rank
#99
of 274 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CELC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JNBA Financial Advisors holds $3,807,089 across 13 Biotechnology names. CELC ranks #1 (98.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CELC |
Celcuity Inc.
This page
|
35,753 | $3,740,478 | |
| 2 | TGTX |
Tg Therapeutics, Inc.
|
500 | $27,470 | |
| 3 | TLSA |
Tiziana Life Sciences Ltd
|
12,000 | $15,360 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
140 | $8,010 | |
| 5 | EXEL |
Exelixis, Inc.
|
100 | $5,441 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8 | $3,973 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3 | $1,870 | |
| 8 | CYTK |
Cytokinetics Inc
|
17 | $1,448 |
All Filings in CELC
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,740,478 | 35,753 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $4,080,847 | 35,753 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $3,665,744 | 36,753 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $1,864,998 | 37,753 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $508,514 | 38,091 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $385,100 | 38,091 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $498,611 | 38,091 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $567,936 | 38,091 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $623,930 | 38,091 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $822,765 | 38,091 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $554,985 | 38,091 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $348,151 | 38,091 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $418,239 | 38,091 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $390,432 | 38,091 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $533,654 | 38,091 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $382,433 | 38,091 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $346,628 | 38,091 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $356,150 | 38,091 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $502,420 | 38,091 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $552,330 | 30,685 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $498,432 | 20,768 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $297,813 | 20,768 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $190,234 | 20,768 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $120,454 | 20,768 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $143,922 | 20,768 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $134,992 | 20,768 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||